SGLT2 inhibitors in the real world: too good to be true?

被引：8
|
作者：
Fitchett, David [1 ,2 ]
机构：
[1] St Michaels Hosp, Div Cardiol, Toronto, ON M5B 1W8, Canada
[2] Univ Toronto, Dept Med, Toronto, ON, Canada
来源：
LANCET DIABETES & ENDOCRINOLOGY | 2017年 / 5卷 / 09期
关键词：
CARDIOVASCULAR OUTCOMES;
D O I：
10.1016/S2213-8587(17)30259-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：673 / 675
页数：4
相关论文
共 50 条
  • [1] SGLT2 inhibitors and kidney outcomes in the real world
    Smith, Steven M.
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 369
  • [2] SGLT2 INHIBITORS IN IGA NEPHROPATHY: REAL-WORLD CLINICAL PRACTICE
    Garcia Carro, Clara
    Aiffil Meneses, Arianne
    Lopez Martinez, Marina
    Velo, Mercedes
    Rodriguez-Moreno, Antolina
    Soler Romeo, Maria Jose
    Sanchez Fructuoso, Ana
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I397 - I398
  • [3] As Good as it Gets: SGLT2 Inhibitors in Cardiac Amyloidosis
    Pinney, Sean P.
    Costanzo, Maria Rosa
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (24) : 2423 - 2425
  • [4] SGLT2 inhibitors as add on therapy in type 2 diabetes: A real world study
    Tamez-Perez H.E.
    Delgadillo-Esteban E.
    Soni-Duque D.
    Hernández-Coria M.I.
    Tamez-Peña A.L.
    Journal of Diabetes & Metabolic Disorders, 16 (1):
  • [5] SGLT Inhibitors for Type 1 Diabetes: An Obvious Choice or Too Good to Be True?
    Riddle, Matthew C.
    Cefalu, William T.
    DIABETES CARE, 2018, 41 (12) : 2444 - 2447
  • [6] SGLT2 INHIBITORS
    Brito, M.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E162 - E162
  • [7] SGLT2 inhibitors
    Dardi, I.
    Kouvatsos, T.
    Jabbour, S. A.
    BIOCHEMICAL PHARMACOLOGY, 2016, 101 : 27 - 39
  • [8] SGLT2 inhibitors
    Steyn, Lynda
    SA PHARMACEUTICAL JOURNAL, 2018, 85 (01) : 72 - 75
  • [9] A real-world study on SGLT2 inhibitors and diabetic kidney disease progression
    Liu, Allen Yan Lun
    Low, Serena
    Yeoh, Ester
    Lim, Eng Kuang
    Renaud, Claude Jeffrey
    Teoh, Selene Tse Yen
    Tan, Grace Feng Ling
    Chai, Chung Cheen
    Liu, Bo
    Subramaniam, Tavintharan
    Sum, Chee Fang
    Lim, Su Chi
    CLINICAL KIDNEY JOURNAL, 2022, 15 (07) : 1403 - 1414
  • [10] Renoprotective Effects of SGLT2 Inhibitors in Japanese Real-World Clinical Practice
    Tosaki, Takahiro
    Sato, Shiori Toga
    Kondo, Masaki
    Yamada, Yuichiro
    Inagaki, Akemi
    Tsunekawa, Shin
    Himeno, Tatsuhito
    Kato, Yoshiro
    Nakamura, Jiro
    Kamiya, Hideki
    DIABETES, 2019, 68
12345